Advanced Filters
noise

Colonia Centro, Mexico Clinical Trials

A listing of Colonia Centro, Mexico clinical trials actively recruiting patients volunteers.

Found 133 clinical trials
L Lenny N Gallardo-Alvarado, Md, MSc

Chemotherapy and Pelvic Hypofractionated Radiation Followed by Surgery Cervical Cancer

The purpose of the study is to evaluate the role of hypofractionated in the treatment of locally advanced cervical cancer. The study will be conducted in Honduras and Mexico, and patients will be randomized to a standard fraction (45 Gy in 25 fractions) or hypofractionated (37.5Gy in 15 fractions) followed …

18 - 80 years of age Female Phase N/A
D David F Cantu-de Leon, Md, PhD

Chemotherapy and Pelvic Hypofractionated Radiation Followed by Brachytherapy for Cervical Cancer

The main goal of this trial is to assess the safety and response rate to concomitant chemotherapy and external hypofractionated radiotherapy followed by brachytherapy in patients with clinical stage III cervical cancer. The trial will take place in the National Cancer Institute (INCan). Patients will be randomized into two groups: …

18 years of age Female Phase N/A
M Marlid Cruz Ramos, PhD

Improving Lifestyle Behavior by "Joven, Fuerte y Saludable" Multidisciplinary Program.

Breast cancer is the leading cause of mortality in women worldwide. Latin-American women are diagnosed at younger ages, in advanced stages, and with aggressive molecular subtypes. Lifestyle seems related to these aggressive conditions and worse outcomes. The present study seeks to evaluate the effect of a hybrid multidisciplinary intervention for …

18 - 40 years of age Female Phase N/A
O Oscar V Hernández Mondragón, MD

Efficacy of Fistulotomy for Biliary Cannulation

Access to the main bile duct is the first step in order to perform a therapeutic maneuver for biliary diseases. Early precut has been shown to ameliorate cannulation success rate, specially in difficult cannulation cases, when compared to guidewire cannulation (which is considered, for most, the standard technique). We aim …

18 - 90 years of age All Phase N/A

Glutamine Plus L. Reuteri Prevents TKI Therapy-diarrhea in Patients With NSCLC

This open-label randomized clinical trial aims to evaluate the glutamine plus Lactobacillus reuteri supplementation effect in a standard-of-care diet in EGFR mutant patients with advanced non-small cell lung cancer (NSCLC) under tyrosine kinase inhibitors (TKIs) therapy. The main question it aims to answer is ¿What is the effect of glutamine …

18 - 80 years of age All Phase 3
M María Fernanda Pérez Hernández, MD

Effect of Electroacupuncture on Sensitive Symptoms of Distal Diabetic Peripheral Neuropathy

This is a controlled clinical trial with the aim to study the effects of electroacupuncture on neuropathic pain reduction, quality of life and changes in sensory and motor nerve conduction velocity in patients with type 2 diabetes mellitus, beneficiaries of the familiar medical centers 20, 40 and 41 of the …

40 - 75 years of age All Phase N/A
Y Yara Luna

Study to Assess Safety and Tolerability of Multiple Doses of EO2002

The goal of this clinical study is to assess the safety of multiple intracameral injections of EO2002 with and without topical Ripasudil.

18 years of age All Phase 1
A Ana María Escalante-Gonzalbo, MCSc

Changes in Motor and Cognitive Function on Unilateral Spastic Cerebral Palsy, Associated With Videogame Therapy

The use of interactive applications associated with position and movement sensors has begun to spread as an option for the reinforcement of physical rehabilitation therapies in patients with congenital or acquired motor disorders as a result of some neurological damage, due to its portability and the relative autonomy granted to …

5 - 18 years of age All Phase N/A

Clinical Study of a Fluid Accommodating Intraocular Lens (IOL) Design

The purpose of this clinical study is to evaluate the surgical, refractive, and visual outcomes with implantation of an investigational intraocular lens (IOL).

22 years of age All Phase N/A
O Oscar G Arrieta Rodriguez, M.D., M.Sc.

Alectinib Pharmacokinetic in Patients With NSCLC

This interventional study aims to determine the pharmacokinetics of orally administered alectinib with dose escalation from 300 mg to 600 mg twice daily in Mexican patients with advanced ALK-positive NSCLC. The main question it aims to answer is: what will be the peak plasma concentrations of alectinib following sequential dose …

18 years of age All Phase 1/2

Simplify language using AI